shellennessee • Retweets are Not Endorsements. (@shellennessee) header
shellennessee • Retweets are Not Endorsements. (@shellennessee) profile picture

Child of God, Servant of Jesus, Mom, Grandma, Patriot, Copy Editor, Author of “Master Fibonacci: The Man Who Changed Math”

NOTW
Joined July 2020
Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)Photo by shellennessee • Retweets are Not Endorsements. (@shellennessee)
I added this PowerPoint presentation to my website today. I am hoping many people will find it helpful. Law of War Manual: Chapter 11 - Military Occupation ruthlessredpen.com/?p=1304&p… Please feel free to share. #DepartmentOfDefense #LawOfWar #belligerentoccupiers
4
5
14
612
shellennessee • Retweets are Not Endorsements. retweeted
Replying to @digijordan
Well thank God, Jesus Christ is in Control
1
4
13
400
shellennessee • Retweets are Not Endorsements. retweeted
MOST-WANTED SINALOA CARTEL LEADER CAPTURED IN MEXICO Fausto Isidro Meza Flores, alias “Chapo Isidro,” an FBI Ten Most Wanted fugitive and leader of the Beltrán Leyva faction of the Sinaloa Cartel, was arrested in Mexico alongside his top lieutenant, Germán Rolando Gálvez Meza. The arrests followed a joint HSI and @FBI investigation under the @HSTaskForce, in coordination with Mexican authorities. Meza Flores faces federal charges of narcoterrorism, material support of terrorism, and continuing criminal enterprise, carrying a potential sentence of life in prison or death if convicted. This is a MAJOR blow to one of Mexico’s most powerful cartel networks. Through the Homeland Security Task Force, HSI and our law enforcement partners are taking down cartel kingpins at the highest levels, dismantling their criminal empires, and cutting off the organizations that traffic deadly drugs into American communities.
19
205
15
933
27,793
shellennessee • Retweets are Not Endorsements. retweeted
My graph starts in 1895. Your charts start in the 1960s. You only get an increase in U.S. heatwave frequency if you deliberately exclude the hot summers of the 1925–54 period. Wanna try again or do you need another beatdown?
This quoted post is unavailable.
76
1,254
38
6,421
75,136
shellennessee • Retweets are Not Endorsements. retweeted
Congratulations to our partners at @Defensamx on the Nov. 20 capture of Fausto Isidro N, an @FBI Ten Most Wanted fugitive, and two associates in Sinaloa. @JIATFCC, in coordination with other U.S. interagency partners, supported the targeting effort that led to this capture. Bilateral cooperation delivers results against transnational criminal organizations. #USNORTHCOM #JIATFCC @DeptofWar @PatrickWeaverPA @DOWResponse @PressSecDOW @USAmbMex
Se informa que, derivado de la coordinación entre organismos de inteligencia de la Secretaría de la Defensa Nacional y de los E.U.A., realizada en el marco de la cooperación bilateral con ese país, el 20 de noviembre del presente año, Fuerzas Especiales de la Guardia Nacional (Lobos) y del Ejército (Murciélagos), en coordinación con elementos de Fuerzas Especiales del Ejército comisionados en la Secretaría de Seguridad Pública del Estado de Sinaloa, detuvieron en el municipio de Guasave, Sin., a Fausto Isidro N (a) “Chapo Isidro”, jefe de la organización delictiva “Beltrán Leyva” y aliado al “Cártel del Pacífico” facción “Mayos”, a Germán N (a) “Serafín”, segundo al mando de esa organización delincuencial y a José N, operador financiero de este mismo grupo delictivo. (a) “Chapo Isidro”, cuenta con una orden de aprehensión en México por delincuencia organizada y por cometer delitos contra la salud, y una orden de extradición a los E.U.A. por asociación delictiva para distribuir droga en territorio estadounidense; además, se encuentra en la lista de los 10 fugitivos más buscados por el F.B.I. La operación para estas detenciones, fue realizada por fuerzas militares de élite, las que una vez ubicado con precisión el objetivo, mediante el empleo de diversos ingenios tecnológicos, la desarrollaron en 3 fases, de la forma siguiente: Arribo al área del objetivo: se realizó utilizando el sigilo y la sorpresa por diferentes vías de acceso terrestre al área de la detención. Establecimiento de la seguridad y captura del objetivo: esta se realizó a inmediaciones de la ubicación de los detenidos, mediante la colocación de un dispositivo de seguridad interna y externa, para evitar la huida o la llegada de refuerzos, habiendo sido agredidos con disparos de armas de fuego y explosivos, por lo que la fuerza de detención ingresó a la casa habitación para capturar a las personas indicadas. Evacuación del objetivo: confirmada la identidad de los detenidos, se procedió a su evacuación a la Ciudad de México, en una aeronave de la Fuerza Aérea Mexicana, para ser puestos a disposición de las autoridades ministeriales competentes. Derivado de esta detención, se registraron bloqueos en los municipios de Ahome, Guamúchil, Guasave y Navolato, para lo cual, en coordinación con autoridades locales, se activó el plan antibloqueo, movilizando fuerzas de seguridad para restablecer el tránsito en las vías de comunicación y proteger a la población. #NoticiadeÚltimaHora #ComunicadoDePrensa #EjércitoMexicano #FuerzaAéreaMx #GuardiaNacional
38
317
23
1,693
49,739
shellennessee • Retweets are Not Endorsements. retweeted
Se informa que, derivado de la coordinación entre organismos de inteligencia de la Secretaría de la Defensa Nacional y de los E.U.A., realizada en el marco de la cooperación bilateral con ese país, el 20 de noviembre del presente año, Fuerzas Especiales de la Guardia Nacional (Lobos) y del Ejército (Murciélagos), en coordinación con elementos de Fuerzas Especiales del Ejército comisionados en la Secretaría de Seguridad Pública del Estado de Sinaloa, detuvieron en el municipio de Guasave, Sin., a Fausto Isidro N (a) “Chapo Isidro”, jefe de la organización delictiva “Beltrán Leyva” y aliado al “Cártel del Pacífico” facción “Mayos”, a Germán N (a) “Serafín”, segundo al mando de esa organización delincuencial y a José N, operador financiero de este mismo grupo delictivo. (a) “Chapo Isidro”, cuenta con una orden de aprehensión en México por delincuencia organizada y por cometer delitos contra la salud, y una orden de extradición a los E.U.A. por asociación delictiva para distribuir droga en territorio estadounidense; además, se encuentra en la lista de los 10 fugitivos más buscados por el F.B.I. La operación para estas detenciones, fue realizada por fuerzas militares de élite, las que una vez ubicado con precisión el objetivo, mediante el empleo de diversos ingenios tecnológicos, la desarrollaron en 3 fases, de la forma siguiente: Arribo al área del objetivo: se realizó utilizando el sigilo y la sorpresa por diferentes vías de acceso terrestre al área de la detención. Establecimiento de la seguridad y captura del objetivo: esta se realizó a inmediaciones de la ubicación de los detenidos, mediante la colocación de un dispositivo de seguridad interna y externa, para evitar la huida o la llegada de refuerzos, habiendo sido agredidos con disparos de armas de fuego y explosivos, por lo que la fuerza de detención ingresó a la casa habitación para capturar a las personas indicadas. Evacuación del objetivo: confirmada la identidad de los detenidos, se procedió a su evacuación a la Ciudad de México, en una aeronave de la Fuerza Aérea Mexicana, para ser puestos a disposición de las autoridades ministeriales competentes. Derivado de esta detención, se registraron bloqueos en los municipios de Ahome, Guamúchil, Guasave y Navolato, para lo cual, en coordinación con autoridades locales, se activó el plan antibloqueo, movilizando fuerzas de seguridad para restablecer el tránsito en las vías de comunicación y proteger a la población. #NoticiadeÚltimaHora #ComunicadoDePrensa #EjércitoMexicano #FuerzaAéreaMx #GuardiaNacional
383
1,844
201
13,990
1,184,262
shellennessee • Retweets are Not Endorsements. retweeted
Replying to @martingeddes
With you tonight in spirit. You are helping me understand the world better, and doing so with innovative yet rigorous analysis. There IS a psychic load to this fight. May we pace ourselves well so that we can sustain for as long as it takes. Heaven knows how to put a proper price on its goods.
5
35
885
shellennessee • Retweets are Not Endorsements. retweeted
An Iranian writes in support of Monday’s protests: “From Savadkuh to Abdanan, my life is for Iran” “Forever and ever, long live the Shah” November 20, 2026
3
179
3
471
3,852
shellennessee • Retweets are Not Endorsements. retweeted
GREAT NEWS: The United States forced the UN to take a vote on abortion this week, and the UN could not get a majority of nations to support killing babies in abortions. Only 72 of 193 countries would go on record supporting killing babes in abortions. lifenews.com/2026/11/20/amer…
111
1,111
71
3,307
28,321
shellennessee • Retweets are Not Endorsements. retweeted
Call the White House. Tell President Trump you want free and fair elections. Tell him you will not accept these fraudulent elections. Make the call. Tell everyone you know to make the call. When the public speaks, he responds.
167
1,556
60
2,919
49,878
shellennessee • Retweets are Not Endorsements. retweeted
Denmark's parliament just voted UNANIMOUSLY to expand the U.S. military presence in Greenland, handing President Trump a major Arctic defense agreement after months of tensions over his push to acquire the strategically important territory. On November 19, all 109 lawmakers present in Denmark's Folketing voted to ratify a security agreement negotiated between the United States, Denmark, and Greenland, with no opposition or abstentions. The agreement, signed September 22 by the three governments, updates a defense arrangement dating back to 1951 and significantly expands American military access to Greenland. Under the new deal, the United States can modernize and expand operations at Pituffik Space Base, establish additional defense areas at Narsarsuaq in southern Greenland and Mestersvig on the eastern coast, and pursue military infrastructure supporting Trump's proposed Golden Dome missile defense system. The expanded access strengthens America's ability to monitor threats across the Arctic and North Atlantic, regions that have become increasingly important to U.S. and NATO security. The agreement also explicitly preserves Danish sovereignty over Greenland and recognizes the Greenlandic people's right to self-determination, meaning the territory remains under the Kingdom of Denmark rather than becoming American territory. Greenland's parliament approved the agreement on November 3, and Denmark's unanimous vote clears the final parliamentary hurdle. The pact will take effect once Denmark formally notifies the United States that the necessary procedures are complete. The agreement follows months of negotiations after Trump's repeated statements about acquiring Greenland sparked diplomatic tensions with Denmark and Greenlandic leaders. With parliamentary approval now secured, the United States is positioned to expand its military footprint in one of the world's most strategically important regions without changing Greenland's political status. #Greenland #Denmark #ArcticSecurity
1
6
37
2,217
shellennessee • Retweets are Not Endorsements. retweeted
Don't go chasing waterfalls. Unless they're at Delaware Water Gap National Recreation Area. Sorry, TLC. Dingmans Falls plunges 130 feet through Pennsylvania's Pocono Mountains, where brilliant fall colors make one of the state's tallest waterfalls even more spectacular.
52
208
18
1,625
64,201
shellennessee • Retweets are Not Endorsements. retweeted
Fake News won't cover it, so here's your cheat sheet on some of the wins President Trump delivered in less than two years. ⬇️ First president in American history to achieve net deregulation Ended DEI Ended transgender insanity Fully secured the border Record deportations Record-low crime Record-low murder rate Record production of American fossil fuels Record production of American coal First nuclear reactors to go critical since the 1970s Rebalanced global trade Rebuilt the military Rebuilt the entire federal law enforcement apparatus Took on drug cartels using lethal force for the first time in American history Took over Venezuela in less than an hour, doubling U.S. oil reserves Reformed relationships with Russia and China Strong economy Fastest wage growth Defeated inflation inherited from the Biden administration
3,455
6,128
384
22,626
553,493
shellennessee • Retweets are Not Endorsements. retweeted
🔴 Dirty Bomb Scares, Tech Meltdowns, Crimea Bridge Attack — Why Now? nitter.gq/i/broadcasts/2QneEggvK…
42
625
18
1,586
50,242
shellennessee • Retweets are Not Endorsements. retweeted
The Trump Admin is delivering greater transparency. 🇺🇸 Americans can now access SEC’s EDGAR (Electronic Data Gathering, Analysis, & Retrieval) database through America.gov to easily find company info & reports, putting accurate, real-time data directly at your fingertips.
In collaboration with @ndstudio, we’re excited to share that EDGAR content is now available through America.gov 🎉 This enhancement expands access to market information, helping investors, researchers, market participants, and the public interact with EDGAR data in new, informative ways. Check it out below ⬇️
589
1,576
60
6,462
280,530
Replying to @MidwesternDoc
Food and Drug Administration (FDA) This U.S. federal agency (part of the Department of Health and Human Services) is responsible for regulating food, drugs, medical devices, tobacco, biologics, cosmetics, and related products. FDA commissioners and political appointees set direction and can force big changes, but the people who have been at the FDA the longest (career center and office leaders plus rank-and-file reviewers) hold most of the ongoing operational and scientific power. The agency’s continuity depends far more on them than on the rotating commissioners. The agency is a hierarchical federal bureaucracy under the Department of Health and Human Services (HHS). The Commissioner sits at the top, but real operational and scientific power is distributed—especially to the center directors and the large career workforce beneath them. Who Has Been There the Longest? Commissioners turn over with administrations (or sooner). Continuity comes from career civil servants, many of whom spend 10–30+ years at the agency. High turnover in recent years has reduced the number of ultra-long-tenured senior leaders, but some remain, particularly at the center or office-director level and below. Notable longer-serving examples (past and present): Michelle Tarver, M.D., Ph.D. (Director, Center for Devices and Radiological Health / CDRH): ~15+ years at FDA (joined ~2009). She is one of the more durable current center directors. Bret Koplow, Ph.D., J.D. (Director, Center for Tobacco Products): At FDA since around 2011. Richard Pazdur, M.D. (longtime oncology leader; briefly CDER director): ~26 years (joined 1999). He recently retired after decades of influence on cancer drug regulation. Historical long-servers included Janet Woodcock (decades in drug review and leadership roles) and Peter Marks (long CBER tenure). Many of the longest-serving people are mid-to-senior career reviewers, office directors, and managers whose names rarely make headlines. Who Truly Holds Real Decision-Making Power? Power is layered: Political leadership (highest formal authority, shortest tenure)
The Commissioner (currently Acting Commissioner Kyle Diamantas) and, above them, the HHS Secretary set overall priorities, policy direction, and can intervene in high-profile or politically sensitive matters. They serve at the pleasure of the President and typically last 1–4 years. They can push major initiatives or override on selected issues, but they do not personally review the thousands of product applications. Center Directors (major operational power)
These roles have some of the greatest day-to-day influence over product regulation: CDER (drugs) — Michael Davis, M.D., Ph.D. CBER (biologics, vaccines, gene/cell therapies) — Karim Mikhail CDRH (medical devices) — Michelle Tarver, M.D., Ph.D. Human Foods Program, Tobacco, Veterinary, etc.
 Center directors oversee scientific reviews, approval standards, and policy within their domains. They are often career or long-serving officials and wield significant practical authority. Career reviewers, managers, and office directors (the institutional engine)
The bulk of technical decisions—whether a drug or device is safe and effective, inspection findings, labeling, etc.—are made by thousands of career scientists, physicians, and reviewers. They provide continuity, deep expertise, and institutional knowledge that outlasts any commissioner. Political leadership generally sets the framework; career staff execute most individual product decisions (though recent years have seen more top-down involvement in certain areas). nitter.gq/i/grok/share/c2hhcmQtM… Grok
2
shellennessee • Retweets are Not Endorsements. retweeted
In 1991, the FDA held a hearing on whether antidepressants like Prozac could trigger suicide and violence. Patient after patient testified. Then an FDA staffer read out the conflict-of-interest waivers granted to the committee members: Merck, Sandoz, Eli Lilly, Pfizer. And then they voted. 🧵
11
211
8
504
19,934
Replying to @MidwesternDoc
Food and Drug Administration (FDA) This U.S. federal agency (part of the Department of Health and Human Services) is responsible for regulating food, drugs, medical devices, tobacco, biologics, cosmetics, and related products. FDA commissioners and political appointees set direction and can force big changes, but the people who have been at the FDA the longest (career center and office leaders plus rank-and-file reviewers) hold most of the ongoing operational and scientific power. The agency’s continuity depends far more on them than on the rotating commissioners. The agency is a hierarchical federal bureaucracy under the Department of Health and Human Services (HHS). The Commissioner sits at the top, but real operational and scientific power is distributed—especially to the center directors and the large career workforce beneath them. Who Has Been There the Longest? Commissioners turn over with administrations (or sooner). Continuity comes from career civil servants, many of whom spend 10–30+ years at the agency. High turnover in recent years has reduced the number of ultra-long-tenured senior leaders, but some remain, particularly at the center or office-director level and below. Notable longer-serving examples (past and present): Michelle Tarver, M.D., Ph.D. (Director, Center for Devices and Radiological Health / CDRH): ~15+ years at FDA (joined ~2009). She is one of the more durable current center directors. Bret Koplow, Ph.D., J.D. (Director, Center for Tobacco Products): At FDA since around 2011. Richard Pazdur, M.D. (longtime oncology leader; briefly CDER director): ~26 years (joined 1999). He recently retired after decades of influence on cancer drug regulation. Historical long-servers included Janet Woodcock (decades in drug review and leadership roles) and Peter Marks (long CBER tenure). Many of the longest-serving people are mid-to-senior career reviewers, office directors, and managers whose names rarely make headlines. Who Truly Holds Real Decision-Making Power? Power is layered: Political leadership (highest formal authority, shortest tenure)
The Commissioner (currently Acting Commissioner Kyle Diamantas) and, above them, the HHS Secretary set overall priorities, policy direction, and can intervene in high-profile or politically sensitive matters. They serve at the pleasure of the President and typically last 1–4 years. They can push major initiatives or override on selected issues, but they do not personally review the thousands of product applications. Center Directors (major operational power)
These roles have some of the greatest day-to-day influence over product regulation: CDER (drugs) — Michael Davis, M.D., Ph.D. CBER (biologics, vaccines, gene/cell therapies) — Karim Mikhail CDRH (medical devices) — Michelle Tarver, M.D., Ph.D. Human Foods Program, Tobacco, Veterinary, etc.
 Center directors oversee scientific reviews, approval standards, and policy within their domains. They are often career or long-serving officials and wield significant practical authority. Career reviewers, managers, and office directors (the institutional engine)
The bulk of technical decisions—whether a drug or device is safe and effective, inspection findings, labeling, etc.—are made by thousands of career scientists, physicians, and reviewers. They provide continuity, deep expertise, and institutional knowledge that outlasts any commissioner. Political leadership generally sets the framework; career staff execute most individual product decisions (though recent years have seen more top-down involvement in certain areas). nitter.gq/i/grok/share/c2hhcmQtM… Grok
14
Here are the last 5 Senate-confirmed FDA Commissioners (from the official FDA list and contemporary reporting), with approximate tenure lengths and reasons they left. Note that there were often acting commissioners in the gaps between them, and remember: Center directors (not commissioners) hold the greatest operational power. Name & Title Tenure Approx. Length Why They Left Martin A. Makary, M.D., M.P.H. 27th Commissioner - March 25, 2025 – May 13, 2026 ~14 months - Resigned amid mounting political and internal pressure. Key factors included clashes with the White House (especially over approval of flavored e-cigarettes/vapes), tensions with HHS leadership, industry criticism over drug reviews, and broader management turmoil at the agency. Reports indicated the flavored-vape dispute was a proximate trigger; he resigned rather than face likely removal. Kyle Diamantas then became Acting Commissioner. Robert M. Califf, M.D. 26th Commissioner (second term) - February 17, 2022 – January 20, 2025 ~3 years - Left at the end of the Biden administration / presidential transition (standard for political appointees). He completed his term and departed as the new administration took office. Stephen M. Hahn, M.D. 25th Commissioner - December 17, 2019 – January 20, 2021 ~13 months - Left at the end of the Trump administration / presidential transition. His tenure was dominated by the early COVID-19 pandemic and related political pressures. Scott Gottlieb, M.D. 24th Commissioner - May 11, 2017 – April 5, 2019 ~23 months - Resigned voluntarily. He publicly cited the personal toll of commuting from Connecticut and the desire to spend more time with his family (wife and three young children). The departure was relatively amicable. Robert M. Califf, M.D. 23rd Commissioner (first term) - February 24, 2016 – January 20, 2017 ~11 months - Left at the end of the Obama administration / presidential transition. Notes • These are the confirmed Commissioners. Acting Commissioners (e.g., Janet Woodcock after Hahn, Sara Brenner briefly after Califf in early 2025, and currently Kyle Diamantas) filled gaps but are not listed as full Commissioners on the official FDA page. • Most departures of confirmed Commissioners are tied to changes in presidential administration. Makary’s exit was more abrupt and politically driven than the others. • Tenure lengths are approximate and based on the official start/end dates listed by the FDA. • For the full historical list, the FDA maintains an official page of Commissioners dating back to 1907. - Grok
1
47
Food and Drug Administration (FDA) This U.S. federal agency (part of the Department of Health and Human Services) is responsible for regulating food, drugs, medical devices, tobacco, biologics, cosmetics, and related products. FDA commissioners and political appointees set direction and can force big changes, but the people who have been at the FDA the longest (career center and office leaders plus rank-and-file reviewers) hold most of the ongoing operational and scientific power. The agency’s continuity depends far more on them than on the rotating commissioners. The agency is a hierarchical federal bureaucracy under the Department of Health and Human Services (HHS). The Commissioner sits at the top, but real operational and scientific power is distributed—especially to the center directors and the large career workforce beneath them. Who Has Been There the Longest? Commissioners turn over with administrations (or sooner). Continuity comes from career civil servants, many of whom spend 10–30+ years at the agency. High turnover in recent years has reduced the number of ultra-long-tenured senior leaders, but some remain, particularly at the center or office-director level and below. Notable longer-serving examples (past and present): Michelle Tarver, M.D., Ph.D. (Director, Center for Devices and Radiological Health / CDRH): ~15+ years at FDA (joined ~2009). She is one of the more durable current center directors. Bret Koplow, Ph.D., J.D. (Director, Center for Tobacco Products): At FDA since around 2011. Richard Pazdur, M.D. (longtime oncology leader; briefly CDER director): ~26 years (joined 1999). He recently retired after decades of influence on cancer drug regulation. Historical long-servers included Janet Woodcock (decades in drug review and leadership roles) and Peter Marks (long CBER tenure). Many of the longest-serving people are mid-to-senior career reviewers, office directors, and managers whose names rarely make headlines. Who Truly Holds Real Decision-Making Power? Power is layered: Political leadership (highest formal authority, shortest tenure)
The Commissioner (currently Acting Commissioner Kyle Diamantas) and, above them, the HHS Secretary set overall priorities, policy direction, and can intervene in high-profile or politically sensitive matters. They serve at the pleasure of the President and typically last 1–4 years. They can push major initiatives or override on selected issues, but they do not personally review the thousands of product applications. Center Directors (major operational power)
These roles have some of the greatest day-to-day influence over product regulation: CDER (drugs) — Michael Davis, M.D., Ph.D. CBER (biologics, vaccines, gene/cell therapies) — Karim Mikhail CDRH (medical devices) — Michelle Tarver, M.D., Ph.D. Human Foods Program, Tobacco, Veterinary, etc.
 Center directors oversee scientific reviews, approval standards, and policy within their domains. They are often career or long-serving officials and wield significant practical authority. Career reviewers, managers, and office directors (the institutional engine)
The bulk of technical decisions—whether a drug or device is safe and effective, inspection findings, labeling, etc.—are made by thousands of career scientists, physicians, and reviewers. They provide continuity, deep expertise, and institutional knowledge that outlasts any commissioner. Political leadership generally sets the framework; career staff execute most individual product decisions (though recent years have seen more top-down involvement in certain areas). nitter.gq/i/grok/share/c2hhcmQtM… Grok
1
1
1
1
108
shellennessee • Retweets are Not Endorsements. retweeted
Six years ago today, thanks to President Trump’s leadership, we started in earnest the journey of realizing President Kennedy’s vision of a special force for a new form of conflict. Still a long way to go.
340
2,217
239
7,205
307,607